Emcure Pharma IPO GMP today is at a significant high and it has been soaring even before its subscription. The IPO has been in the news for its grey market premium as well as its link with Shark Tank-fame Namita Thapar. Now, there is a third factor coming in the news and that is Emcure Pharma IPO subscription, which starts July 3. Considering the substantial interest in the IPO, investors would be looking at gaining insight into what is likely to happen to this stock.
How good is the company, are the promoters up to generating future growth and profit as per investor expectations, is the market large enough, how good and expansive is the company vision? All these questions would be at the forefront of all considerations for investors. However, over and above that, is one thing that every potential investor would be keeping an eye on and that is Emcure Pharma IPO GMP today.
In the mix is Shark Tank-fame Namita Thapar as she has been a long term investor with 3.5 per cent stake (63 lakh shares). She is a Whole-Time-Director of the Pune-based company. She is reducing her stake through the Offer For Sale (OFS). Thapar is expected to earn Rs 127 crore at the upper end of the price band, from the Emcure Pharma IPO. Satish Ramanlal Mehta, Sunil Rajanikant Mehta, and Samit Satish Mehta are the other promoters.
Emcure Pharma IPO GMP today
Emcure Pharma IPO GMP today stands at Rs 290. On Monday it was Rs 264. Combined with the grey market premium and Emcure Pharma IPO price band of between Rs 960 to Rs 1,008 (upper end), Emcure Pharma IPO listing date gains may well be 28.77 per cent. The estimated Emcure Pharma IPO listing price may be Rs 1298.
Emcure Pharma IPO subscription, allotment, listing
Notably, Emcure Pharma IPO Anchor Investor subscription was held on July 2. The Emcure Pharma IPO subscription opens July 3 and the last day is July 5, with the stock market debut set to happen on the NSE and the BSE.
As far as quotas are concerned, the retail portion is reserved at 35%, the Non-Institutional Investors’ (NIIs) quota is 15% and the Qualified Institutional Investors’ (QIBs) quota is 50%.
Among the other important there is Emcure Pharma IPO Allotment date. This has been slated for Monday, July 8.
And after a gap of a couple of days, Emcure Pharma IPO Listing is set to happen, which is on Wednesday, July 10.
The proceeds from Emcure Pharma IPO will be used for purposes of paying back debt as well as other corporate purposes.
Emcure Pharma IPO size is Rs 1,952 crore that including a fresh issue of 0.79 crore shares aggregating to Rs 800 crore and an Offer For Sale (OFS) of 1.14 crore shares aggregating to Rs 1,152.03 crore.
(Disclaimer: This article is only meant to provide information. News9live.com does not recommend buying or selling shares or subscriptions of any IPO and Mutual Funds.)
Emcure Pharma IPO subscription starts tomorrow and investors would be eyeing various factors before investing. Among them is Emcure Pharma IPO GMP today as well as Namita Thapar stake sale. Markets Business News – Personal Finance News, Share Market News, BSE/NSE News, Stock Exchange News Today
